本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

19.91
+0.47002.42%
盘后19.910.00000.00%18:29 EDT
成交量:194.90万
成交额:3,915.59万
市值:25.02亿
市盈率:-11.08
高:20.59
开:19.58
低:19.25
收:19.44
数据加载中...
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/01

重要事件披露

Form 8-K - Current report
2023/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/08

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/03

关联方拟减持公告

144 - Report of proposed sale of securities